ATX 9 Mar 2026, 8:14 AM

Benefit of Narmafotinib in kRas-Mutated Cancer Models

Amplia Therapeutics Ltd

No summary is available for this announcement — open the PDF to read it in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in